Form 4: Cheryl Scott Receives Restricted Stock Units in Evolent Health, Inc.

Cheryl Scott, a director at Evolent Health, Inc., was granted 7,709 restricted stock units on June 6, 2024, under the company's 2015 Omnibus Incentive Compensation Plan.

Summary

• Cheryl Scott, a director of Evolent Health, Inc., reported a transaction on Form 4.
• On June 6, 2024, Ms. Scott was granted 7,709 restricted stock units (RSUs) under the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
• These RSUs will vest on the earlier of June 6, 2025, or the date of the company's 2025 annual meeting, contingent upon Ms. Scott's continued service.
• Following the transaction, Ms. Scott beneficially owns 51,497 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard equity compensation practices for a company director, indicating alignment of interests.

Positives

• The grant of restricted stock units aligns Ms. Scott's interests with those of the company and its shareholders.
• The vesting schedule incentivizes continued service and commitment to Evolent Health, Inc.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the restricted stock units.

Industry Context

Equity compensation is a common practice in the healthcare industry to attract and retain talent, aligning the interests of executives and directors with those of shareholders.

Stakeholder Impact

• The grant of RSUs to a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates